Journal of the National Comprehensive Cancer Network : JNCCN · 2018
Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
von Mehren Margaret, Randall R Lor, Benjamin Robert S, Boles Sarah, Bui Marilyn M, Ganjoo Kristen N, George Suzanne, Gonzalez Ricardo J, Heslin Martin J, Kane John M, Keedy Vicki, Kim Edward, Koon Henry, Mayerson Joel, McCarter Martin, McGarry Sean V, Meyer Christian, Morris Zachary S, O'Donnell Richard J, Pappo Alberto S, Paz I Benjamin, Petersen Ivy A, Pfeifer John D, Riedel Richard F, Ruo Bernice, Schuetze Scott, Tap William D, Wayne Jeffrey D, Bergman Mary Anne, Scavone Jillian L
Аннотация
Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Guidelines for STS provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as intra-abdominal/retroperitoneal STS, gastrointestinal stromal tumors, desmoid tumors, and rhabdomyosarcoma. This portion of the NCCN Guidelines discusses general principles for the diagnosis, staging, and treatment of STS of the extremities, superficial trunk, or head and neck; outlines treatment recommendations by disease stage; and reviews the evidence to support the guidelines recommendations.